Daiichi Sankyo has entered into an exclusive licence agreement worth up to $300m with Alteogen to develop a subcutaneous ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...

Alteogen Inc. (KOSDAQ:196170) announced today that the company has entered into an exclusive license agreement with Daiichi Sankyo (TSE: 4568). Under the terms of the agreement, Daiichi Sankyo will ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

DAIICHI is the No. 1 car seat manufacturer in Korea with a 50% market share. Founded in 2001, DAIICHI is a car seat company that is loved by customers for its made in Korea car seats called the ...

ALT-B4 is Alteogen's proprietary human recombinant hyaluronidase enzyme developed utilizing HybrozymeTM technology. ALT-B4 can enable the large volume subcutaneous administration of drugs that are ...

SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- DAIICHI, a leading car seat company in Korea, has launched the portable car seat 'Easy Carry 2' and portable stroller 'The Space' in Indonesia ...

Founded in 2001, DAIICHI is a car seat company that is loved by customers for its made in Korea car seats called the 'national car seat' in Korea. In addition, DAIICHI is a baby products company ...

SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- DAIICHI, a leading car seat company in Korea, has launched the portable car seat 'Easy Carry 2' and portable stroller 'The Space' in Indonesia, ...